Catalent Opens New Facility in San Diego
Catalent announced the opening of a new facility in San Diego. The new facility marks the latest expansion to Catalent’s global clinical supply network and follows the opening of a new site in Japan earlier this month. The 24,000-square-foot facility has been established to support clinical studies in Phases I-III. The site offers end-to-end services including supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Talvey Plus Tecvayli Shows Promising Results in Multiple Myeloma but Raises Infection Concerns
January 9th 2025A Phase Ib/II dose escalation and expansion trial shows promising antitumor activity and durable responses with Talvey (talquetamab) plus Tecvayli (teclistamab) in the treatment of relapsed or refractory multiple myeloma, but a higher incidence of grade 3 or 4 infections.
